Cryptosporidium virulence determinants--are we there yet?
Exposure to Cryptosporidium parvum in healthy individuals results in transient infection that may be asymptomatic or can result in self-limited diarrhoea. In contrast, acquired immune deficiency syndrome patients with cryptosporidiosis can experience severe manifestations of disease. Volunteer studies have demonstrated that as few as 10 oocysts can cause infection in otherwise healthy adults and that isolates from geographically diverse regions differ in infectivity and, perhaps, virulence. Variability in isolate pathogenicity and infectivity has also been seen in bovine and murine models, respectively. Furthermore, isolate specific differences in protein composition and in host immunoreactivity have been observed. The molecular basis for differences in pathogenicity is not understood. Determining which factors are responsible for host selectivity and for the initiation, establishment, and perpetuation of infection with Cryptosporidium is key to rational drug design and vaccine development. To date, no specific virulence factors have been unequivocally shown to individually cause direct or indirect damage to host tissues nor have mutant strains been produced that could prove that particular deletions result in less virulent strains. Nevertheless, a number of candidate molecules have been identified by immunological and molecular methods. Here, we review the salient characteristics of some of these putative virulence determinants, including molecules that are involved in adhesion, protein degradation and the modulation of the host responses.
Okhuysen
Pablo C
PC
Department of Medicine, Division of Infectious Diseases and The School of Public Health, The University of Texas Health Science Center at Houston Medical School, 6431 Fannin, 1.728 JFB, Houston, TX 77030, USA. pablo.c.okhuysen@uth.tmc.edu
Chappell
Cynthia L
CL
D000328:Adult; D000818:Animals; D002648:Child; D003457:Cryptosporidiosis / Q000469:parasitology*; D003458:Cryptosporidium / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D015800:Protozoan Proteins / Q000235:genetics / Q000378:metabolism*; D014774:Virulence / Q000235:genetics
D015800:Protozoan Proteins